Press release
Immunofluorescence Analyzer Market Witness Significant Growth | Abbott Laboratories, bioMerieux, EMD Millipore, Siemens Healthcare, Thermo Fisher Scientific,
The advantages of a fluorescent detection system include higher sensitivity recognition of an analyte, simpler assay designs, and simplified reagents. Over the past few decades various advancements such as portability, compactness and real time monitoring of analyzer have supported the application of fluorescent-based immunoassay system in point-of-care. A modern immunofluorescence assay-based analyzer uses a florescent compound that absorbs light energy at a specific wavelength and emits energy at a different wavelength. The difference between these light energy is called strokes shift. Immunofluorescence assay analyzers are extensively used in the field of clinical diagnostics, research and development, and quality control. Lack of skilled workforce and increasing test volume have led to the growth of immunofluorescence analyzer market size.Request to Sample Report @ https://www.coherentmarketinsights.com/insight/request-sample/1794
Increasing number of innovative products that are developed by clinical diagnostic manufacturers from the results of clinical and preclinical trials research is boosting the immunofluorescence analyzer market growth. For instance, in 2016, AESKU group received clearance from the Food and Drug Administration (FDA) for its new HELIOS automated immunofluorescence system with AESKUSLIDES ANA HEp-2-Gamma assay. HELIOS is based upon automated system for the immunofluorescence processing with image recapturing with an integrated software and fluorescence microscope. In a single run, HELIOS can process and analyze patient samples. Over 300 HELIOS systems are used worldwide in clinical research in over 40 countries.
Moreover, significance of care is now shifting towards early detection and prevention of diseases. Therefore, private companies are investing huge amount of capital for the development of rapid diagnostic testing solutions and low cost imaging technologies for point-of-care testing. For instance, in 2017, the Food and Drug Administration provided clearance to Quidel’s point-of-care Sofia® 2 immunoassay analyzer for use with Sofia influenza A+B assay. The next generation version, Sofia 2, is based on Quidel’s bestselling Sofia instrumented system. Sofia 2 is integrated with wireless connectivity and uses the florescent chemistry design with optics system to provide automated, accurate results in 3 minutes.
Request TOC of the Report @ https://www.coherentmarketinsights.com/ongoing-insight/toc/1794
On the basis of region, the global immunofluorescence analyzer market is segmented into North America, Asia Pacific, Latin America, Europe, Middle East, and Africa. North America immunofluorescence analyzer market accounts for the largest share in the global market, owing to rising adoption of innovative technologies in the region. For instance, in 2017, Siemens Healthineers launched the Atellica Solution, an immunoassay and clinical chemistry solution that is highly flexible, which included patented magnetic bi-directional sample transport technology that is 10 times quicker than conventional system. The solution can be used as scalable stand-alone system that offers 300 customizable configurations including U-shaped and L-shaped, and is scalable up to 10 components.
Moreover, Asia Pacific is expected to witness significant growth in the market over the forecast period, owing to the large number of population vulnerable to various chronic diseases and increasing adoption of new technologies. For instance, in 2014, Sysmex Corporation launched a compact immunochemistry testing automated immunoassay system HISCL-800, which has high degree of sensitivity, minute samples, fast measurement, and high operability as well as compactness.
Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/1794
Key players operating in the global immunofluorescence analyzer market include Abbott Laboratories, bioMerieux, EMD Millipore, Siemens Healthcare, Thermo Fisher Scientific, and DiaSorin S.p.A. Major players are focused towards adopting strategies such as launch of new innovative products to boost their product portfolio and hold their position in the market. For instance, in 2017, Abbott received FDA approval for its Alinity ci-series instruments. The portfolio includes immunoassay diagnostics, clinical chemistry, blood and plasma screening, point-of-care, hematology, and AlinIQ holistic suite, which provides professional services with informatics and process analysis.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Immunofluorescence Analyzer Market Witness Significant Growth | Abbott Laboratories, bioMerieux, EMD Millipore, Siemens Healthcare, Thermo Fisher Scientific, here
News-ID: 1734925 • Views: …
More Releases from Coherent Market Insights

Poppy Seeds Market 2032 Industry Overview, Evolution Growth Rate and Future Fore …
The Poppy Seeds market is estimated to be valued at USD 341.3 Mn in 2025 and is expected to reach USD 506.8 Mn by 2032, growing at a compound annual growth rate CAGR of 5.8% from 2025 to 2032.
➤ The latest study, of the global Poppy Seeds Market presents an in-depth evaluation of current market dynamics, key players, regional trends, market segments, applications, and growth opportunities, with forecasts extending from…

Global Supply Chain Security Market Size 2025 Emerging Demands, Share, Trends, F …
The Global Supply Chain Security Market is estimated to be valued at USD 2.64 Bn in 2025 and is expected to reach USD 5.62 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 11.4% from 2025 to 2032.
The latest research study released by Coherent Market Insights on "Supply Chain Security Market 2025 Forecast to 2032" research provides accurate economic, global, and country-level predictions and analyses. It provides a…

Global Mobile Cloud Market Size 2025 Emerging Demands, Share, Trends, Futuristic …
The Global Mobile Cloud Market is estimated to be valued at USD 72.43 Bn in 2025 and is expected to reach USD 284.74 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 21.6% from 2025 to 2032.
The latest research study released by Coherent Market Insights on "Mobile Cloud Market 2025 Forecast to 2032" research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective…

Vendor Management Systems Market Share & Growth 2025: Investment Opportunities a …
The Global Vendor Management Systems Market is estimated to be valued at USD 10.42 Bn in 2025 and is expected to reach USD 20.69 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 10.30% from 2025 to 2032.
The latest research study released by Coherent Market Insights on "Vendor Management Systems Market 2025 Forecast to 2032" research provides accurate economic, global, and country-level predictions and analyses. It provides a…
More Releases for Immunofluorescence
Rising Chronic Disease Prevalence Driving Growth In Immunofluorescence Assay Mar …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
What Is the Expected CAGR for the Immunofluorescence Assay Market Through 2025?
In recent times, we've witnessed the substantial growth of the immunofluorescence assay market. The market, worth $3.34 billion in 2024, is projected to reach a value of $3.59 billion in 2025, which equates to a compound annual growth rate (CAGR) of 7.4%.…
Key Trends Shaping the Future Immunofluorescence Assay Market From 2025-2034: Te …
What market dynamics are playing a key role in accelerating the growth of the immunofluorescence assay market?
Rising cases of chronic illnesses are substantially propelling the growth of the immunofluorescence assay market. Shifting lifestyle patterns, food routines, and poor weight control are promoting the swift proliferation of chronic conditions, with specific prolonged chronic infections posing a threat of evolving into cancer. These escalating incidences of chronic disorders are anticipated to fuel…
Immunofluorescence Assay Market Report 2024 - Immunofluorescence Assay Market Si …
"The Business Research Company recently released a comprehensive report on the Global Immunofluorescence Assay Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…
Immunofluorescence Market Current Business Trend & Growth Opportunity
Market Analysis and Insights of Immunofluorescence Market
Immunofluorescence Market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to grow at a CAGR of 5.4% in the above-mentioned forecast period.
Immunofluorescence is defined as the technique used to visualize structures such as intermediate-sized filaments, and utilizes light microscopy in combination with fluorescence microscope on various microbiological samples. The various microbiological…
Immunofluorescence Analyzer Market: Views Sought On New Approach
The Global Immunofluorescence Analyzer Market has witnessed continuous growth in the past few years and is projected to grow even further during the forecast period (2020-2027). The research presents a complete assessment of the market and contains Future trend, Current Growth Factors, attentive opinions, facts, historical data, and statistically supported and industry validated market data.
Immunofluorescence Analyzer Market report presents the detail analysis of the parent market based on elite players,…
Global Immunofluorescence Assay Market – Forecast to 2026
Based on the GME predictions, the Global Immunofluorescence Assay Market would grow with a CAGR value of 6.25%and cross USD 3.50 billion by 2026. Immunofluorescence Assay (IFA) is also known as a usual virologic technique used to identify the existence of antibodies in infected cells.The demand for Immunofluorescence Assay is indirectly related to the rate of diseases
Browse 153 Market Data Tables and 113 Figures spread through 183 Pages and in-depth…